Start an analysis for ELA
Envela Corporation
Stock · AMEXProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $1mEST | 30-Sep-26 | 10-Q filed 17-Nov-26 |
| Remaining authorization | $839.1kEST | 30-Sep-26 | 10-Q filed 17-Nov-26 |
| Program expiry | 31-Mar-28 | 30-Sep-26 | 10-Q filed 17-Nov-26 |
| Repurchased last quarter | $1m | 30-Sep-26 | 10-Q filed 17-Nov-26 |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 27-Mar-25 | $1mEST 100,000 sh | $839.1kEST 71,410 sh left | 31-Mar-28 | On March 27, 2025, the Board authorized the repurchase of an additional 100 thousand shares of the Common Stock, bringing the total authorization under the existing program to 1.1 million shares.10-Q filed 17-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 17-Nov-26 |
| 31-Aug-26 | 67,435 | $15.84 | $1m | 10-Q filed 17-Nov-26 |
| 31-Jul-26 | 0 | — | $0 | 10-Q filed 17-Nov-26 |